Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 6
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer.
Andrikopoulou A, Theofanakis C, Markellos C, Kaparelou M, Koutsoukos K, Apostolidou K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F, Liontos M. Andrikopoulou A, et al. Among authors: markellos c. Cancers (Basel). 2023 Jul 6;15(13):3519. doi: 10.3390/cancers15133519. Cancers (Basel). 2023. PMID: 37444629 Free PMC article.
CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience.
Andrikopoulou A, Fiste O, Apostolidou K, Skafida E, Markellos C, Liontos M, Kyriazoglou A, Dimopoulos MA, Zagouri F. Andrikopoulou A, et al. Among authors: markellos c. Med Sci (Basel). 2021 Jun 5;9(2):42. doi: 10.3390/medsci9020042. Med Sci (Basel). 2021. PMID: 34198899 Free PMC article.
Olive oil intake and cancer risk: A systematic review and meta-analysis.
Markellos C, Ourailidou ME, Gavriatopoulou M, Halvatsiotis P, Sergentanis TN, Psaltopoulou T. Markellos C, et al. PLoS One. 2022 Jan 11;17(1):e0261649. doi: 10.1371/journal.pone.0261649. eCollection 2022. PLoS One. 2022. PMID: 35015763 Free PMC article.
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition.
Terpos E, Liontos M, Fiste O, Zagouri F, Briasoulis A, Sklirou AD, Markellos C, Skafida E, Papatheodoridi A, Andrikopoulou A, Koutsoukos K, Kaparelou M, Iconomidou VA, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: markellos c. Cancers (Basel). 2022 Jun 4;14(11):2796. doi: 10.3390/cancers14112796. Cancers (Basel). 2022. PMID: 35681774 Free PMC article.
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.
Liontos M, Terpos E, Kunadis E, Zagouri F, Briasoulis A, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Gumeni S, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Liontos M, et al. Among authors: markellos c. Prostate Cancer Prostatic Dis. 2022 Mar;25(1):117-118. doi: 10.1038/s41391-021-00455-9. Epub 2021 Oct 9. Prostate Cancer Prostatic Dis. 2022. PMID: 34628475 Free PMC article.
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.
Zagouri F, Papatheodoridi A, Liontos M, Briasoulis A, Sklirou AD, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Koutsoukos K, Kaparelou M, Gkogkou E, Trougakos IP, Dimopoulos MA, Terpos E. Zagouri F, et al. Among authors: markellos c. Vaccines (Basel). 2022 Sep 5;10(9):1474. doi: 10.3390/vaccines10091474. Vaccines (Basel). 2022. PMID: 36146552 Free PMC article.
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors.
Liontos M, Terpos E, Markellos C, Zagouri F, Briasoulis A, Katsiana I, Skafida E, Fiste O, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Liontos M, et al. Among authors: markellos c. Vaccines (Basel). 2021 Oct 8;9(10):1148. doi: 10.3390/vaccines9101148. Vaccines (Basel). 2021. PMID: 34696256 Free PMC article.
13 results